NEMAURA MEDICAL INC Share

$0.04

29.10% today

Nasdaq, Jul 02, 03:30 pm CET

ISIN

US6404421090

Symbol

NMRD

Reports

Quarter | Year

Index

NASDAQ Composite

Sector

Health

Industry

Medical specialties

Overview Dividends Analysts Charts News Strategies

NEMAURA MEDICAL INC Share price

$0.05

-9.85 99.46% 5Y

Nasdaq, Closing price Mon, Jul 01 2024

-0.00 8.22%

ISIN

US6404421090

Symbol

NMRD

Reports

Quarter | Year

Index

NASDAQ Composite

Sector

Health

Industry

Medical specialties

Key metrics

Market capitalization	$2.16m
Enterprise Value	$21.66m
PER (TTM) P/E ratio	negative
EV/FCF (TTM) EV/FCF	negative
P/B ratio (TTM) P/B ratio	negative
Sales growth (TTM) Sales growth	-100.00%
Turnover (TTM) Turnover	$0.00
EBIT (operating result TTM) EBIT	$-9.30m
Free cash flow (TTM) Free cash flow	$-9.74m
Cash position	$140.00k
EPS (TTM) EPS	$-0.38
P/S ratio expected	9.10
EV/Sales expected	106.60
Short interest	0.31%

As a free StocksGuide basic user, you can view the scores for all 6,954 shares worldwide.

Get Started for Free Today

NEMAURA MEDICAL INC Share analysis

Unlock Scores for Free

??

1 Analyst has issued a forecast NEMAURA MEDICAL INC:

1x Buy

100%

More details on analyst estimates including price targets

1 Analyst has issued a forecast NEMAURA MEDICAL INC:

Buy

100%

Analyst estimates incl. share price targets

Financial data from NEMAURA MEDICAL INC

Income Statement P&L | Balance Sheet | Cash Flow

Quarter Annually

Assets

Dec '23
Current assets	4.37 4.37
Cash position	0.14 0.14
Claims	0.25 0.25
Inventories	3.67 3.67
Other current assets Other current assets Current assets	0.32 0.32

Fixed assets	0.80 0.80
Property, plant and equipment	0.56 0.56
Financial assets	- -
Intangible assets	0.24 0.24
Other fixed assets Other assets Fixed assets	- -


Total assets	5.17 5.17

Liabilities

Dec '23
Equity	-18 -18

Debt capital	23 23
Current liabilities	23 23
Non-current liabilities	- -


Total capital	5.17 5.17

Figures in millions USD.

If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.

Subscribe to news free of charge

NEMAURA MEDICAL INC Share News

Neutral

GlobeNewsWire

●

6 months ago

Important Update on Listing Status and Strategic Direction

Loughborough, UK, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (“Nemaura Medical” or the “Company”), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs, is providing a crucial update regarding recent decisions that will impact Nemaura Medical's listing status on The Nasdaq Capital Market and our broader strategic direction.

Neutral

GlobeNewsWire

●

7 months ago

Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision

Loughborough, UK, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura Medical” or the “Company”), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs is pleased to announce that the Nasdaq Hearings Panel granted the Company's request for continued listing pursuant to an exception, including certain interim milestones, that ultimatel...

Neutral

GlobeNewsWire

●

7 months ago

Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth

Loughborough, UK, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura Medical” or the “Company”), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs is pleased to announce the execution of a strategic agreement for a $10 million credit facility which is expected to support the Company's strategic growth plans.

More NEMAURA MEDICAL INC News

Company profile

Nemaura Medical, Inc. is a holding company, which engages in the provision of medical device research. Through its subsidiaries, it manufactures and commercializes continuous glucose monitoring system, named sugarBEAT. The sugarBEAT is consist of a disposable adhesive skin-patch connected to a rechargeable wireless transmitter that displays glucose readings at regular five minute intervals with the use of a mobile app. The company was founded by Dewan Fazlul Hoque Chowdhury on December 24, 2013 and is headquartered in Loughborough, the United Kingdom.

Head office	United States
CEO	Dewan Chowdhury
Employees	38
Founded	2013
Website	www.nemauramedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now